2. WHAT IS DOTS?
Established byWHO in 1993 as a result of poor adherence to treatment plan byTB
patients
Involves direct observation by a health-care provider watching patient swallow their
tablets, in a way that is sensitive & supportive to the patient’s needs.
Is an important element in the internationally recommended policy package forTB
control.
It ensures that the patient takes:
The right anti-TB drugs
At the right doses
And at the right intervals
May be done in clinical setting or in the community.
3. (CONT’D):
Drugs should remain with the observer & should be given to the patient ONLY AT
THETIME OF INTAKE.
It is required to ensure treatment adherence
Helps to reinforce patient’s motivation to continue treatment.
DOTS also ensure accountability ofTB services & help prevent emergence of drug
resistance.
In general, family members of the patient SHOULD NOT serve as treatment
observers.
Successful candidates who may serve as treatment observers are:
Healthcare providers
Community member-also HIV/AIDS community care scheme workers
Cured patients
4. RECOMMENDED FOR:
Homeless people & drifters
Alcohol & drug users
Patients with serious mental illness
Those with a history of non-compliance
5. WHAT IS INVOLVED?
It basically consists of a combination chemotherapy: HRZE
(H-isoniazid; R-rifampicin;Z-pyrazinamide; E-ethambutol)
Regimens with daily, twice-weekly or thrice-weekly for 2-6 months have been
devised.
Hence, strategy leads to cure in about 95% of cases (roughly 85% of new cases!).
6. 5 COMPONENTS OF DOTS:
1) GOVERNMENT COMMITMENT(sustained political commitment).
2) CASE DETECTION BY SPUTUM SMEAR MICROSCOPY.
3) STANDARDIZEDTREATMENT REGIMEN
4) DRUG SUPPLY
5) STANDARDIZED RECORDING & REPORTING SYSTEM
That allows assessment of treatment results.
7. ADDITIONAL:
The DOTS program needs government support & funding to achieve a long-term
TB control.
The result of not instituting such a plan is obvious-increased numbers of cases of
TB, MDR-TB & deaths.